I'm going back to the announcement made by the company on March 30, announcing the appointment of Julius Matthys to the position of interim CEO. Quote: "Julius will commence as interim CEO with effect from Monday 3 April 2017 beginning with a review of Quintis' operations and outlook". I emphasise: REVIEW of QUINTIS' OPERATIONS AND OUTLOOK".
If, in more than a month of reviewing the situation, the only announcement made was the one about the Galderma contract, perhaps there's room for very, very, VERY CAUTIOUS optimism.
- Forums
- ASX - By Stock
- QIN
- just doubled my holdings
just doubled my holdings, page-2
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost